These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23477070)

  • 1. [Prostate cancer and androgen deprivation: benefits of psychological counseling].
    Frambati L; Weber K; Canuto A; Miralbell R; Zilli T; Pichard C; Joly C; Voison N; Santos JF
    Rev Med Suisse; 2013 Feb; 9(373):369-70, 372-3. PubMed ID: 23477070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing the side effects of androgen deprivation therapy.
    J Support Oncol; 2006 Feb; 4(2):97-8. PubMed ID: 16499136
    [No Abstract]   [Full Text] [Related]  

  • 3. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.
    DiBlasio CJ; Malcolm JB; Derweesh IH; Womack JH; Kincade MC; Mancini JG; Ogles ML; Lamar KD; Patterson AL; Wake RW
    BJU Int; 2008 Jul; 102(1):39-43. PubMed ID: 18294309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life.
    Elliott S; Latini DM; Walker LM; Wassersug R; Robinson JW;
    J Sex Med; 2010 Sep; 7(9):2996-3010. PubMed ID: 20626600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metastatic prostate cancer].
    Droz JP; Flechon A; Terret C
    Rev Prat; 2003 Dec; 53(20):2258-62. PubMed ID: 15018080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapy.
    Mareschal J; Weber K; Rigoli P; Biason E; Frambati L; Gotteland C; Zilli T; Pichard C; Miralbell R
    Acta Oncol; 2017 Apr; 56(4):569-574. PubMed ID: 28075176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications of androgen deprivation therapy in prostate cancer.
    Schwandt A; Garcia JA
    Curr Opin Urol; 2009 May; 19(3):322-6. PubMed ID: 19318949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quality-of-life issues.
    Gomella LG
    BJU Int; 2007 Jan; 99 Suppl 1():25-9; discussion 30. PubMed ID: 17229166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex or survival: short-term versus long-term androgen deprivation in patients with locally advanced prostate cancer treated with radiotherapy.
    Wilke DR; Krahn M; Tomlinson G; Bezjak A; Rutledge R; Warde P
    Cancer; 2010 Apr; 116(8):1909-17. PubMed ID: 20162716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
    Teloken PE; Ohebshalom M; Mohideen N; Mulhall JP
    J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing complications of androgen deprivation therapy for prostate cancer.
    Holzbeierlein JM
    Urol Clin North Am; 2006 May; 33(2):181-90, vi. PubMed ID: 16631456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of androgen deprivation therapy: prevention and treatment.
    Holzbeierlein JM; Castle E; Thrasher JB
    Oncology (Williston Park); 2004 Mar; 18(3):303-9; discussion 310, 315, 319-21. PubMed ID: 15065701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the management of patients with prostate cancer receiving long-term androgen deprivation therapy.
    Schulman C; Irani J; Aapro M
    BJU Int; 2012 Jun; 109 Suppl 6():13-21. PubMed ID: 22672121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unique needs of couples experiencing androgen deprivation therapy for prostate cancer.
    Walker LM; Robinson JW
    J Sex Marital Ther; 2010; 36(2):154-65. PubMed ID: 20169495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications.
    Krupski TL; Foley KA; Baser O; Long S; Macarios D; Litwin MS
    J Urol; 2007 Oct; 178(4 Pt 1):1423-8. PubMed ID: 17706711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of the side effects of androgenic deprivation].
    Lebret T; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S338-42. PubMed ID: 19070813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do patient-reported androgen-deprivation therapy side effects predict anxiety and depression among prostate cancer patients undergoing radiotherapy? Implications for psychosocial therapy interventions.
    Sharpley CF; Bitsika V; Christie DR
    J Psychosoc Oncol; 2012; 30(2):185-97. PubMed ID: 22416955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with therapy of prostate cancer in the Primorye Territory].
    Gurina LI; Iudin SV
    Vopr Onkol; 2004; 50(5):599-601. PubMed ID: 15715105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of androgen in the elderly. Problems of androgen deprivation therapy].
    Tsujimura A
    Clin Calcium; 2013 Aug; 23(8):1185-90. PubMed ID: 23892220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.